GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29)

 2A5G_HUMAN              Reviewed;         524 AA.
Q13362; B4DYJ8; B5BUA5; F5GWP3; Q14391; Q15060; Q15174; Q6ZN33;
30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
17-OCT-2006, sequence version 3.
07-APR-2021, entry version 202.
RecName: Full=Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform;
AltName: Full=PP2A B subunit isoform B'-gamma;
AltName: Full=PP2A B subunit isoform B56-gamma;
AltName: Full=PP2A B subunit isoform PR61-gamma;
AltName: Full=PP2A B subunit isoform R5-gamma;
AltName: Full=Renal carcinoma antigen NY-REN-29;
Name=PPP2R5C; Synonyms=KIAA0044;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GAMMA-3).
TISSUE=Umbilical vein;
PubMed=8617797; DOI=10.1074/jbc.271.9.5164;
Tehrani M.A., Mumby M.C., Kamibayashi C.;
"Identification of a novel protein phosphatase 2A regulatory subunit highly
expressed in muscle.";
J. Biol. Chem. 271:5164-5170(1996).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GAMMA-1).
TISSUE=Fetal retina;
PubMed=8694763; DOI=10.1042/bj3170187;
Zolnierowicz S., van Hoof C., Andjelkovic N., Cron P., Stevens I.,
Merlevede W., Goris J., Hemmings B.A.;
"The variable subunit associated with protein phosphatase 2A0 defines a
novel multimember family of regulatory subunits.";
Biochem. J. 317:187-194(1996).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND PARTIAL NUCLEOTIDE
SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
TISSUE=Hippocampus, and Testis;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GAMMA-3).
PubMed=19054851; DOI=10.1038/nmeth.1273;
Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H., Maruyama Y.,
Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R., Murase A.,
Nishikawa A., Nishikawa S., Okamoto T., Sakagami N., Sakamoto Y.,
Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T., Takayama T.,
Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H., Yanagisawa Y.,
Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T., Imai J., Watanabe S.,
Nomura N.;
"Human protein factory for converting the transcriptome into an in vitro-
expressed proteome.";
Nat. Methods 5:1011-1017(2008).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=12508121; DOI=10.1038/nature01348;
Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
Waterston R., Hood L., Weissenbach J.;
"The DNA sequence and analysis of human chromosome 14.";
Nature 421:601-607(2003).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
Hunkapiller M.W., Myers E.W., Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-524 (ISOFORM GAMMA-2).
TISSUE=Bone marrow;
PubMed=7584044; DOI=10.1093/dnares/1.5.223;
Nomura N., Nagase T., Miyajima N., Sazuka T., Tanaka A., Sato S., Seki N.,
Kawarabayasi Y., Ishikawa K., Tabata S.;
"Prediction of the coding sequences of unidentified human genes. II. The
coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of
cDNA clones from human cell line KG-1.";
DNA Res. 1:223-229(1994).
[8]
NUCLEOTIDE SEQUENCE [MRNA] OF 11-524 (ISOFORM GAMMA-1).
PubMed=7592815; DOI=10.1074/jbc.270.44.26123;
McCright B., Virshup D.M.;
"Identification of a new family of protein phosphatase 2A regulatory
subunits.";
J. Biol. Chem. 270:26123-26128(1995).
[9]
PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
PubMed=8703017; DOI=10.1074/jbc.271.36.22081;
McCright B., Rivers A.M., Audlin S., Virshup D.M.;
"The B56 family of protein phosphatase 2A (PP2A) regulatory subunits
encodes differentiation-induced phosphoproteins that target PP2A to both
nucleus and cytoplasm.";
J. Biol. Chem. 271:22081-22089(1996).
[10]
IDENTIFICATION AS A RENAL CANCER ANTIGEN.
TISSUE=Renal cell carcinoma;
PubMed=10508479;
DOI=10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5;
Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
Old L.J.;
"Antigens recognized by autologous antibody in patients with renal-cell
carcinoma.";
Int. J. Cancer 83:456-464(1999).
[11]
IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH SGO1, AND SUBCELLULAR
LOCATION.
PubMed=16580887; DOI=10.1016/j.devcel.2006.03.010;
Tang Z., Shu H., Qi W., Mahmood N.A., Mumby M.C., Yu H.;
"PP2A is required for centromeric localization of Sgo1 and proper
chromosome segregation.";
Dev. Cell 10:575-585(2006).
[12]
FUNCTION, INTERACTION WITH IER3 AND ERK KINASES, AND PHOSPHORYLATION.
PubMed=16456541; DOI=10.1038/sj.emboj.7600980;
Letourneux C., Rocher G., Porteu F.;
"B56-containing PP2A dephosphorylate ERK and their activity is controlled
by the early gene IEX-1 and ERK.";
EMBO J. 25:727-738(2006).
[13]
INTERACTION WITH SGO1.
PubMed=16541025; DOI=10.1038/nature04663;
Kitajima T.S., Sakuno T., Ishiguro K., Iemura S., Natsume T.,
Kawashima S.A., Watanabe Y.;
"Shugoshin collaborates with protein phosphatase 2A to protect cohesin.";
Nature 441:46-52(2006).
[14]
FUNCTION, INTERACTION WITH TP53, AND INDUCTION.
PubMed=17245430; DOI=10.1038/sj.emboj.7601519;
Li H.H., Cai X., Shouse G.P., Piluso L.G., Liu X.;
"A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced
dephosphorylation of p53 at Thr55.";
EMBO J. 26:402-411(2007).
[15]
INTERACTION WITH TP53.
PubMed=17967874; DOI=10.1128/mcb.00983-07;
Shouse G.P., Cai X., Liu X.;
"Serine 15 phosphorylation of p53 directs its interaction with B56gamma and
the tumor suppressor activity of B56gamma-specific protein phosphatase
2A.";
Mol. Cell. Biol. 28:448-456(2008).
[16]
ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=22814378; DOI=10.1073/pnas.1210303109;
Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
"N-terminal acetylome analyses and functional insights of the N-terminal
acetyltransferase NatB.";
Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
[17]
X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 1-442 IN COMPLEX WITH PPP2CA AND
PPP2R1A.
PubMed=17174897; DOI=10.1016/j.cell.2006.11.033;
Xu Y., Xing Y., Chen Y., Chao Y., Lin Z., Fan E., Yu J.W., Strack S.,
Jeffrey P.D., Shi Y.;
"Structure of the protein phosphatase 2A holoenzyme.";
Cell 127:1239-1251(2006).
[18]
X-RAY CRYSTALLOGRAPHY (3.50 ANGSTROMS) OF 30-436 IN COMPLEX WITH PPP2CA AND
PPP2R1A.
PubMed=17086192; DOI=10.1038/nature05351;
Cho U.S., Xu W.;
"Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme.";
Nature 445:53-57(2007).
[19]
X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 34-436 IN COMPLEX WITH PPP2CA;
PPP2R1A AND SGO1.
PubMed=19716788; DOI=10.1016/j.molcel.2009.06.031;
Xu Z., Cetin B., Anger M., Cho U.S., Helmhart W., Nasmyth K., Xu W.;
"Structure and function of the PP2A-shugoshin interaction.";
Mol. Cell 35:426-441(2009).
[20]
X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 11-380.
PubMed=18618707; DOI=10.1002/prot.22150;
Magnusdottir A., Stenmark P., Flodin S., Nyman T., Kotenyova T.,
Graeslund S., Ogg D., Nordlund P.;
"The structure of the PP2A regulatory subunit B56 gamma: the remaining
piece of the PP2A jigsaw puzzle.";
Proteins 74:212-221(2009).
[21]
INTERACTION WITH CIP2A.
PubMed=28174209; DOI=10.15252/embr.201642788;
Wang J., Okkeri J., Pavic K., Wang Z., Kauko O., Halonen T., Sarek G.,
Ojala P.M., Rao Z., Xu W., Westermarck J.;
"Oncoprotein CIP2A is stabilized via interaction with tumor suppressor
PP2A/B56.";
EMBO Rep. 18:437-450(2017).
-!- FUNCTION: The B regulatory subunit might modulate substrate selectivity
and catalytic activity, and also might direct the localization of the
catalytic enzyme to a particular subcellular compartment. The PP2A-
PPP2R5C holoenzyme may specifically dephosphorylate and activate TP53
and play a role in DNA damage-induced inhibition of cell proliferation.
PP2A-PPP2R5C may also regulate the ERK signaling pathway through ERK
dephosphorylation. {ECO:0000269|PubMed:16456541,
ECO:0000269|PubMed:17245430}.
-!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme, composed
of PPP2CA a 36 kDa catalytic subunit (subunit C) and PPP2R1A a 65 kDa
constant regulatory subunit (PR65 or subunit A), that associates with a
variety of regulatory subunits. Proteins that associate with the core
dimer include three families of regulatory subunits B (the
R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56 families), the 48
kDa variable regulatory subunit, viral proteins, and cell signaling
molecules. Interacts with PPP2CA AND PPP2R1A; the interaction is
direct. Interacts with SGO1; the interaction is direct. Isoform 1 and
isoform 2 interact with TP53 (phosphorylated at Ser-15 by ATM);
increased upon DNA damage it drives PP2A-mediated dephosphorylation of
TP53 at Thr-55. Interacts with IER3 and/or ERK kinases; regulates ERK
dephosphorylation. Interacts with CIP2A; this interaction stabilizes
CIP2A (PubMed:28174209). {ECO:0000269|PubMed:16456541,
ECO:0000269|PubMed:16541025, ECO:0000269|PubMed:16580887,
ECO:0000269|PubMed:17086192, ECO:0000269|PubMed:17174897,
ECO:0000269|PubMed:17245430, ECO:0000269|PubMed:17967874,
ECO:0000269|PubMed:19716788, ECO:0000269|PubMed:28174209}.
-!- INTERACTION:
Q13362; P46695: IER3; NbExp=2; IntAct=EBI-1266156, EBI-1748945;
Q13362; Q00987: MDM2; NbExp=5; IntAct=EBI-1266156, EBI-389668;
Q13362; P67775: PPP2CA; NbExp=9; IntAct=EBI-1266156, EBI-712311;
Q13362; P30153: PPP2R1A; NbExp=10; IntAct=EBI-1266156, EBI-302388;
Q13362; P30154: PPP2R1B; NbExp=2; IntAct=EBI-1266156, EBI-357094;
Q13362; P04049: RAF1; NbExp=2; IntAct=EBI-1266156, EBI-365996;
Q13362; P04637: TP53; NbExp=4; IntAct=EBI-1266156, EBI-366083;
Q13362-1; O96017: CHEK2; NbExp=3; IntAct=EBI-1266170, EBI-1180783;
Q13362-1; P30153: PPP2R1A; NbExp=5; IntAct=EBI-1266170, EBI-302388;
Q13362-2; O96017: CHEK2; NbExp=2; IntAct=EBI-1266173, EBI-1180783;
Q13362-2; P30153: PPP2R1A; NbExp=4; IntAct=EBI-1266173, EBI-302388;
Q13362-3; O96017: CHEK2; NbExp=4; IntAct=EBI-1266176, EBI-1180783;
-!- SUBCELLULAR LOCATION: Nucleus. Chromosome, centromere.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=5;
Name=Gamma-3;
IsoId=Q13362-1; Sequence=Displayed;
Name=Gamma-1;
IsoId=Q13362-2; Sequence=VSP_005112;
Name=Gamma-2;
IsoId=Q13362-3; Sequence=VSP_005113;
Name=4;
IsoId=Q13362-4; Sequence=VSP_043645, VSP_005113;
Name=5;
IsoId=Q13362-5; Sequence=VSP_046768;
-!- TISSUE SPECIFICITY: Highest levels in heart, skeletal muscle and brain.
Lower levels in pancreas, kidney, lung and placenta. Very low levels in
liver.
-!- INDUCTION: Up-regulated upon DNA damage. {ECO:0000269|PubMed:17245430}.
-!- PTM: Isoform Gamma-3 is phosphorylated on serine residues. Isoform
Gamma-1 phosphorylation by ERK2 is IER3-dependent and inhibits ERK
dephosphorylation by PP2A-PPP2R5C. {ECO:0000269|PubMed:16456541,
ECO:0000269|PubMed:8703017}.
-!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit B56
family. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=AAC50387.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
Sequence=BAG63760.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
---------------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
---------------------------------------------------------------------------
EMBL; U37352; AAC50387.1; ALT_INIT; mRNA.
EMBL; Z69030; CAA93154.1; -; mRNA.
EMBL; AK131391; BAD18542.1; -; mRNA.
EMBL; AK302470; BAG63760.1; ALT_INIT; mRNA.
EMBL; AB451341; BAG70155.1; -; mRNA.
EMBL; AL118558; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL137779; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471061; EAW81756.1; -; Genomic_DNA.
EMBL; D26445; BAA05465.1; -; mRNA.
EMBL; L42375; AAC37603.1; -; mRNA.
CCDS; CCDS45163.1; -. [Q13362-2]
CCDS; CCDS53911.1; -. [Q13362-4]
CCDS; CCDS53912.1; -. [Q13362-5]
CCDS; CCDS9964.1; -. [Q13362-1]
CCDS; CCDS9965.1; -. [Q13362-3]
RefSeq; NP_001155197.1; NM_001161725.1. [Q13362-5]
RefSeq; NP_001155198.1; NM_001161726.1. [Q13362-4]
RefSeq; NP_002710.2; NM_002719.3. [Q13362-1]
RefSeq; NP_848701.1; NM_178586.2. [Q13362-3]
RefSeq; NP_848702.1; NM_178587.2. [Q13362-2]
RefSeq; XP_005267884.1; XM_005267827.1.
RefSeq; XP_011535222.1; XM_011536920.1.
PDB; 2IAE; X-ray; 3.50 A; B/E=30-436.
PDB; 2JAK; X-ray; 2.60 A; A=11-380.
PDB; 2NPP; X-ray; 3.30 A; B/E=1-442.
PDB; 2NYL; X-ray; 3.80 A; B/E=38-425.
PDB; 2NYM; X-ray; 3.60 A; B/E=38-425.
PDB; 3FGA; X-ray; 2.70 A; B=34-436.
PDB; 5JJA; X-ray; 2.35 A; A/B=30-380.
PDB; 5K6S; X-ray; 2.79 A; A=31-380.
PDB; 5SW9; X-ray; 2.85 A; A=31-380.
PDB; 5SWF; X-ray; 2.82 A; A=31-380.
PDB; 6OYL; X-ray; 3.15 A; A=31-380.
PDB; 6TOQ; X-ray; 3.16 A; AAA=11-380.
PDB; 6VOY; EM; 3.70 A; E/F=30-372.
PDB; 6VRO; X-ray; 2.45 A; A=31-380.
PDB; 6Z2Y; EM; 3.34 A; C/F=11-380.
PDBsum; 2IAE; -.
PDBsum; 2JAK; -.
PDBsum; 2NPP; -.
PDBsum; 2NYL; -.
PDBsum; 2NYM; -.
PDBsum; 3FGA; -.
PDBsum; 5JJA; -.
PDBsum; 5K6S; -.
PDBsum; 5SW9; -.
PDBsum; 5SWF; -.
PDBsum; 6OYL; -.
PDBsum; 6TOQ; -.
PDBsum; 6VOY; -.
PDBsum; 6VRO; -.
PDBsum; 6Z2Y; -.
SMR; Q13362; -.
BioGRID; 111519; 50.
DIP; DIP-39401N; -.
ELM; Q13362; -.
IntAct; Q13362; 31.
MINT; Q13362; -.
STRING; 9606.ENSP00000412324; -.
DrugBank; DB06905; (2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid.
DrugBank; DB02506; 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid.
iPTMnet; Q13362; -.
PhosphoSitePlus; Q13362; -.
SwissPalm; Q13362; -.
BioMuta; PPP2R5C; -.
DMDM; 116241235; -.
jPOST; Q13362; -.
MassIVE; Q13362; -.
MaxQB; Q13362; -.
PaxDb; Q13362; -.
PeptideAtlas; Q13362; -.
PRIDE; Q13362; -.
ProteomicsDB; 24176; -.
ProteomicsDB; 59345; -.
ProteomicsDB; 59346; -. [Q13362-2]
ProteomicsDB; 59347; -. [Q13362-3]
ProteomicsDB; 59348; -. [Q13362-4]
Antibodypedia; 27667; 239 antibodies.
DNASU; 5527; -.
Ensembl; ENST00000328724; ENSP00000329009; ENSG00000078304. [Q13362-4]
Ensembl; ENST00000334743; ENSP00000333905; ENSG00000078304. [Q13362-1]
Ensembl; ENST00000350249; ENSP00000262239; ENSG00000078304. [Q13362-3]
Ensembl; ENST00000422945; ENSP00000412324; ENSG00000078304. [Q13362-5]
Ensembl; ENST00000445439; ENSP00000408389; ENSG00000078304. [Q13362-2]
GeneID; 5527; -.
KEGG; hsa:5527; -.
UCSC; uc001ykk.4; human. [Q13362-1]
CTD; 5527; -.
DisGeNET; 5527; -.
GeneCards; PPP2R5C; -.
HGNC; HGNC:9311; PPP2R5C.
HPA; ENSG00000078304; Low tissue specificity.
MIM; 601645; gene.
neXtProt; NX_Q13362; -.
OpenTargets; ENSG00000078304; -.
PharmGKB; PA33674; -.
VEuPathDB; HostDB:ENSG00000078304.19; -.
eggNOG; KOG2085; Eukaryota.
GeneTree; ENSGT01010000222363; -.
HOGENOM; CLU_012437_3_2_1; -.
InParanoid; Q13362; -.
OMA; ECSQNFN; -.
OrthoDB; 890437at2759; -.
PhylomeDB; Q13362; -.
TreeFam; TF105556; -.
PathwayCommons; Q13362; -.
Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
Reactome; R-HSA-196299; Beta-catenin phosphorylation cascade.
Reactome; R-HSA-2467813; Separation of Sister Chromatids.
Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
Reactome; R-HSA-389513; CTLA4 inhibitory signaling.
Reactome; R-HSA-432142; Platelet sensitization by LDL.
Reactome; R-HSA-4641262; Disassembly of the destruction complex and recruitment of AXIN to the membrane.
Reactome; R-HSA-5339716; Signaling by GSK3beta mutants.
Reactome; R-HSA-5358747; S33 mutants of beta-catenin aren't phosphorylated.
Reactome; R-HSA-5358749; S37 mutants of beta-catenin aren't phosphorylated.
Reactome; R-HSA-5358751; S45 mutants of beta-catenin aren't phosphorylated.
Reactome; R-HSA-5358752; T41 mutants of beta-catenin aren't phosphorylated.
Reactome; R-HSA-5467337; APC truncation mutants have impaired AXIN binding.
Reactome; R-HSA-5467340; AXIN missense mutants destabilize the destruction complex.
Reactome; R-HSA-5467348; Truncations of AMER1 destabilize the destruction complex.
Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
Reactome; R-HSA-5673000; RAF activation.
Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
Reactome; R-HSA-6804757; Regulation of TP53 Degradation.
Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
Reactome; R-HSA-68877; Mitotic Prometaphase.
Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation.
SignaLink; Q13362; -.
SIGNOR; Q13362; -.
BioGRID-ORCS; 5527; 26 hits in 999 CRISPR screens.
ChiTaRS; PPP2R5C; human.
EvolutionaryTrace; Q13362; -.
GeneWiki; PPP2R5C; -.
GenomeRNAi; 5527; -.
Pharos; Q13362; Tbio.
PRO; PR:Q13362; -.
Proteomes; UP000005640; Chromosome 14.
RNAct; Q13362; protein.
Bgee; ENSG00000078304; Expressed in sperm and 244 other tissues.
ExpressionAtlas; Q13362; baseline and differential.
Genevisible; Q13362; HS.
GO; GO:0000775; C:chromosome, centromeric region; IDA:UniProtKB.
GO; GO:0005829; C:cytosol; IDA:HPA.
GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
GO; GO:0005654; C:nucleoplasm; IDA:HPA.
GO; GO:0005634; C:nucleus; IDA:UniProtKB.
GO; GO:0000159; C:protein phosphatase type 2A complex; IDA:UniProtKB.
GO; GO:0072542; F:protein phosphatase activator activity; IBA:GO_Central.
GO; GO:0019888; F:protein phosphatase regulator activity; IDA:UniProtKB.
GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IDA:UniProtKB.
GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:UniProtKB.
GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:UniProtKB.
GO; GO:0051898; P:negative regulation of protein kinase B signaling; TAS:Reactome.
GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:MGI.
GO; GO:0006470; P:protein dephosphorylation; IBA:GO_Central.
GO; GO:0014066; P:regulation of phosphatidylinositol 3-kinase signaling; TAS:Reactome.
GO; GO:0031952; P:regulation of protein autophosphorylation; IBA:GO_Central.
GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
Gene3D; 1.25.10.10; -; 1.
InterPro; IPR011989; ARM-like.
InterPro; IPR016024; ARM-type_fold.
InterPro; IPR002554; PP2A_B56.
PANTHER; PTHR10257; PTHR10257; 1.
Pfam; PF01603; B56; 1.
PIRSF; PIRSF028043; PP2A_B56; 1.
SUPFAM; SSF48371; SSF48371; 1.
1: Evidence at protein level;
3D-structure; Acetylation; Alternative splicing; Centromere; Chromosome;
Nucleus; Phosphoprotein; Reference proteome.
CHAIN 1..524
/note="Serine/threonine-protein phosphatase 2A 56 kDa
regulatory subunit gamma isoform"
/id="PRO_0000071457"
MOTIF 416..422
/note="Nuclear localization signal"
/evidence="ECO:0000255"
MOD_RES 1
/note="N-acetylmethionine"
/evidence="ECO:0007744|PubMed:22814378"
VAR_SEQ 1..31
/note="MLTCNKAGSRMVVDAANSNGPFQPVVLLHIR -> MPNKNKKEKESPKAGKS
GKSSKEGQDTVESEQISVRKNSLVAVPSTVSAKIKVPVSQPIVKKDKRQNSSRFSASNN
RELQKLPSLK (in isoform 4)"
/evidence="ECO:0000303|PubMed:14702039"
/id="VSP_043645"
VAR_SEQ 1..30
/note="MLTCNKAGSRMVVDAANSNGPFQPVVLLHI -> MPNKNKKEKESPKAGKSG
KSSKEGQDTVESEGTSPEEPSSPKVPPPLLPELLVLIFGGLQG (in isoform 5)"
/evidence="ECO:0000305"
/id="VSP_046768"
VAR_SEQ 443..524
/note="YTVYSQASTMSIPVAMETDGPLFEDVQMLRKTVKDEAHQAQKDPKKDRPLAR
RKSELPQDPHTKKALEAHCRADELASQDGR -> VLKKRIT (in isoform
Gamma-1)"
/evidence="ECO:0000303|PubMed:7592815,
ECO:0000303|PubMed:8694763"
/id="VSP_005112"
VAR_SEQ 443..481
/note="Missing (in isoform Gamma-2 and isoform 4)"
/evidence="ECO:0000303|PubMed:14702039,
ECO:0000303|PubMed:7584044"
/id="VSP_005113"
VARIANT 515
/note="A -> P (in dbSNP:rs3742424)"
/id="VAR_051745"
CONFLICT 494
/note="R -> L (in Ref. 1; AAC50387)"
/evidence="ECO:0000305"
HELIX 30..32
/evidence="ECO:0007744|PDB:5JJA"
TURN 35..37
/evidence="ECO:0007744|PDB:5JJA"
HELIX 38..48
/evidence="ECO:0007744|PDB:5JJA"
STRAND 55..57
/evidence="ECO:0007744|PDB:5JJA"
TURN 59..62
/evidence="ECO:0007744|PDB:5JJA"
HELIX 63..82
/evidence="ECO:0007744|PDB:5JJA"
STRAND 83..85
/evidence="ECO:0007744|PDB:5SWF"
HELIX 91..103
/evidence="ECO:0007744|PDB:5JJA"
STRAND 115..118
/evidence="ECO:0007744|PDB:2NPP"
HELIX 120..122
/evidence="ECO:0007744|PDB:3FGA"
HELIX 131..146
/evidence="ECO:0007744|PDB:5JJA"
HELIX 152..155
/evidence="ECO:0007744|PDB:5JJA"
TURN 156..158
/evidence="ECO:0007744|PDB:5JJA"
HELIX 161..169
/evidence="ECO:0007744|PDB:5JJA"
HELIX 170..172
/evidence="ECO:0007744|PDB:5JJA"
HELIX 176..192
/evidence="ECO:0007744|PDB:5JJA"
HELIX 194..196
/evidence="ECO:0007744|PDB:5JJA"
HELIX 197..213
/evidence="ECO:0007744|PDB:5JJA"
HELIX 221..233
/evidence="ECO:0007744|PDB:5JJA"
HELIX 241..249
/evidence="ECO:0007744|PDB:5JJA"
TURN 250..252
/evidence="ECO:0007744|PDB:5JJA"
HELIX 253..256
/evidence="ECO:0007744|PDB:5JJA"
HELIX 260..262
/evidence="ECO:0007744|PDB:5JJA"
HELIX 264..277
/evidence="ECO:0007744|PDB:5JJA"
HELIX 279..281
/evidence="ECO:0007744|PDB:5JJA"
HELIX 282..292
/evidence="ECO:0007744|PDB:5JJA"
HELIX 301..313
/evidence="ECO:0007744|PDB:5JJA"
HELIX 317..335
/evidence="ECO:0007744|PDB:5JJA"
HELIX 340..347
/evidence="ECO:0007744|PDB:5JJA"
HELIX 348..351
/evidence="ECO:0007744|PDB:5JJA"
HELIX 353..360
/evidence="ECO:0007744|PDB:5JJA"
HELIX 363..370
/evidence="ECO:0007744|PDB:5JJA"
TURN 372..374
/evidence="ECO:0007744|PDB:5JJA"
HELIX 384..398
/evidence="ECO:0007744|PDB:3FGA"
HELIX 409..430
/evidence="ECO:0007744|PDB:3FGA"
CONFLICT Q13362-5:3
/note="N -> K (in Ref. 3; BAG63760)"
/evidence="ECO:0000305"
SEQUENCE 524 AA; 61061 MW; B9CBF54550D713F8 CRC64;
MLTCNKAGSR MVVDAANSNG PFQPVVLLHI RDVPPADQEK LFIQKLRQCC VLFDFVSDPL
SDLKWKEVKR AALSEMVEYI THNRNVITEP IYPEVVHMFA VNMFRTLPPS SNPTGAEFDP
EEDEPTLEAA WPHLQLVYEF FLRFLESPDF QPNIAKKYID QKFVLQLLEL FDSEDPRERD
FLKTTLHRIY GKFLGLRAYI RKQINNIFYR FIYETEHHNG IAELLEILGS IINGFALPLK
EEHKIFLLKV LLPLHKVKSL SVYHPQLAYC VVQFLEKDST LTEPVVMALL KYWPKTHSPK
EVMFLNELEE ILDVIEPSEF VKIMEPLFRQ LAKCVSSPHF QVAERALYYW NNEYIMSLIS
DNAAKILPIM FPSLYRNSKT HWNKTIHGLI YNALKLFMEM NQKLFDDCTQ QFKAEKLKEK
LKMKEREEAW VKIENLAKAN PQYTVYSQAS TMSIPVAMET DGPLFEDVQM LRKTVKDEAH
QAQKDPKKDR PLARRKSELP QDPHTKKALE AHCRADELAS QDGR


Related products :

Catalog number Product name Quantity
EIAAB29457 Homo sapiens,Human,PP2A subunit B isoform PR72_PR130,PP2A subunit B isoform R3 isoform,PP2A subunit B isoforms B72_B130,PP2A subunit B isoforms B''-PR72_PR130,PPP2R3,PPP2R3A,Serine_threonine-protein p
EIAAB29458 Homo sapiens,Human,PP2A subunit B isoform PR48,PPP2R3B,PPP2R3L,Protein phosphatase 2A 48 kDa regulatory subunit,Serine_threonine-protein phosphatase 2A regulatory subunit B'' subunit beta
2A5G_MOUSE Mouse ELISA Kit FOR Serine per threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform 96T
E1436r Rabbit ELISA Kit FOR Serine per threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform 96T
H0431 Serine threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform (PPP2R2C), Rat, ELISA Kit 96T
H0428 Serine threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform (PPP2R2C), Human, ELISA Kit 96T
H0430 Serine threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform (PPP2R2C), Rabbit, ELISA Kit 96T
H0429 Serine threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform (PPP2R2C), Mouse, ELISA Kit 96T
2ABG_RAT ELISA Kit FOR Serine per threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform; organism: Rat; gene name: Ppp2r2c 96T
2ABG_MOUSE ELISA Kit FOR Serine per threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform; organism: Mouse; gene name: Ppp2r2c 96T
2A5G_MOUSE ELISA Kit FOR Serine per threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform; organism: Mouse; gene name: Ppp2r5c 96T
GWB-7124AE PROTEIN PHOSPHATASE PP2A 65 KD REGULATORY SUBUNIT BETA ISOFORM (PPP2R1B) Rabbit anti-Rat Polyclonal (aa7-19) Antibody
H0451 Serine threonine-protein phosphatase 2B catalytic subunit gamma isoform (PPP3CC), Mouse, ELISA Kit 96T
H0450 Serine threonine-protein phosphatase 2B catalytic subunit gamma isoform (PPP3CC), Human, ELISA Kit 96T
PP2BC_MOUSE ELISA Kit FOR Serine per threonine-protein phosphatase 2B catalytic subunit gamma isoform; organism: Mouse; gene name: Ppp3cc 96T
201-20-4445 PPP2R2C{protein phosphatase 2 (formerly 2A), regulatory subunit B, gamma isoform}rabbit.pAb 0.2ml
EIAAB29456 Mouse,Mus musculus,PP2A B''-PR59,PP2A PR59,Ppp2r3a,Ppp2r6,Protein phosphatase 2A, 59 kDa regulatory subunit B,Serine_threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha
CSB-EL018566RA Rat Serine_threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform(PPP2R2C) ELISA kit 96T
CSB-EL018566HU Human Serine_threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform(PPP2R2C) ELISA kit 96T
CSB-EL018566MO Mouse Serine_threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform(PPP2R2C) ELISA kit 96T
CSB-EL018566RA Rat Serine_threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform(PPP2R2C) ELISA kit SpeciesRat 96T
EIAAB31927 Calcineurin, testis-specific catalytic subunit,Calmodulin-dependent calcineurin A subunit gamma isoform,Calnc,CAM-PRP catalytic subunit,Mouse,Mus musculus,Ppp3cc,Serine_threonine-protein phosphatase 2
CSB-EL018566HU Human Serine_threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform(PPP2R2C) ELISA kit SpeciesHuman 96T
CSB-EL018566MO Mouse Serine_threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform(PPP2R2C) ELISA kit SpeciesMouse 96T
OBT1345 PPP2R5C (Protein Phosphatase 2, Regulatory subunit B (B56), gamma isoform), B56G, ~37_40kD, Goat atni_Human; WB 100 µg.
Pathways :